RT Journal Article
SR Electronic
T1 Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.22.21250719
DO 10.1101/2021.02.22.21250719
A1 Choi, Yoon Young
A1 Shin, Su-Jin
A1 Lee, Jae Eun
A1 Madlensky, Lisa
A1 Lee, Seung-Tae
A1 Park, Ji Soo
A1 Jo, Jeong-Hyeon
A1 Kim, Hyunki
A1 Nachmanson, Daniela
A1 Xu, Xiaojun
A1 Noh, Sung Hoon
A1 Cheong, Jae-Ho
A1 Harismendy, Olivier
YR 2021
UL http://medrxiv.org/content/early/2021/02/23/2021.02.22.21250719.abstract
AB Background Along with early onset cancers, multiple primary cancers (MPCs) are likely resulting from increased genetic susceptibility; however, the associated predisposition genes or prevalence of the pathogenic variants genes in MPC patients are often unknown.Methods We screened 71 patients with MPC of the stomach, colorectal, and endometrium, sequencing 65 cancer predisposition genes. A subset of 19 patients with early onset MPC of stomach and colorectum were further evaluated for at DNA repair and cancer related genes using both normal (germline) and tumor (somatic) whole exome sequencing.Results Among 71 patients with MPCs, variants predicted to be pathogenic were observed in 15 (21.1%) patients and affected Lynch Syndrome (LS) genes: MLH1 (n=10), MSH6 (n=2), PMS2 (n=2), and MSH2 (n=1). All carriers had tumors with high microsatellite instability and 13 of them (86.7%) were early-onset, consistent with LS. In 19 patients with early-onset MPCs, loss of function (LoF) variants in RECQL5, including a rare East-Asian specific variant, were more prevalent in non-LS MPC than in matched sporadic cancer patients (OR=31.6, p=0.001). Additional evaluation of bi-allelic alterations in the tumor correctly identified LS genes in LS patients and candidates genes in non-LS patients including high-confidence LoF variants in 2 patients, FANCG (c.307+1G>C) and CASP8 (p.R221Sfs*17) both accompanied by somatic loss of heterozygosity in a gastric and a colorectal tumor, respectively.Conclusions The results suggest that genetic screening should be considered for synchronous cancers and metachronous MPCs of the LS tumor spectrum, particularly in early-onset patients. Susceptibility variants in non-LS genes for MPC patients may exist, but evidence for their role is more elusive than for LS patients.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study was not registered in any registry including clinicaltrial.gov.Funding StatementThis work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government. (2017R1D1A1B03032553)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Institutional Review Board (IRB) of Severance Hospital and University of California, San Diego (4-2017-0434, 191543). Patient consent was waived as this study is retrospective design.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset supporting the conclusions of this article is included within the article and its additional file.MPCmultiple primary cancerLSLynch SyndromeCPGcancer predisposition geneLoFloss of functionGCgastric cancerCRCcolorectal cancerMSImicrosatellite instabilityMMRmismatch repairECendometrial cancereoMPCearly-onset multiple primary cancerFFPEformalin fixed paraffin embeddedWESwhole exome sequencingdMMRdeficiency mismatch repairP/LPpathogenic or likely pathogenicAIallelic imbalanceLOHloss of heterozygosityTCGAthe cancer genome atlasMAFminor allele frequency